Richard Nolan Townsend is CEO at Lexeo Therapeutics, Inc. (LXEO). They have made 10 open-market trades across 1 company since 2024, most recently 2026-09-14.
CIK 0001995218
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 10 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| LXEO | 376,778 | $993K |
Shares reported on the most recent Form 4, priced at the 2026-09-28 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| LXEO | SELL | 2026-08-18 | 2026-08-19 | $4.95 | $17K | -10.8% | -21.4% | — |
| LXEO | SELL | 2026-07-01 | 2026-07-01 | $4.48 | $116K | +0.7% | -10.1% | -25.3% |
| LXEO | SELL | 2026-05-18 | 2026-05-20 | $5.06 | $17K | -10.4% | +0.4% | -1.4% |
| LXEO | SELL · 10b5-1 | 2026-04-06 | 2026-04-07 | $5.69 | $313K | +6.5% | -10.5% | -29.3% |
| LXEO | SELL | 2026-02-18 | 2026-02-20 | $6.38 | $65K | +16.4% | -10.9% | -16.2% |
| LXEO | SELL | 2025-11-18 | 2025-11-20 | $9.27 | $10K | -2.1% | +20.1% | -28.9% |
| LXEO | SELL | 2025-10-17 | 2025-10-17 | $8.94 | $234K | +2.4% | -2.1% | -22.5% |
| LXEO | SELL | 2025-08-18 | 2025-09-10 | $4.67 | $5K | +1.7% | +57.9% | +82.2% |
| LXEO | SELL | 2025-08-18 | 2025-08-20 | $4.67 | $13K | +1.1% | +8.6% | +93.7% |
| LXEO | SELL | 2025-05-16 | 2025-05-20 | $2.77 | $3K | -19.8% | +15.3% | +45.1% |
| LXEO | SELL | 2025-02-19 | 2025-02-21 | $4.41 | $19K | -30.7% | +4.6% | -21.2% |
| LXEO | SELL · 10b5-1 | 2024-12-10 | 2024-12-12 | $8.20 | $21K | -9.4% | -9.6% | -58.5% |
| LXEO | SELL · 10b5-1 | 2024-11-11 | 2024-11-13 | $7.82 | $20K | -6.1% | -10.6% | -44.8% |
| LXEO | SELL · 10b5-1 | 2024-10-10 | 2024-10-15 | $8.10 | $41K | +4.9% | -14.1% | -30.0% |
| LXEO | SELL · 10b5-1 | 2024-09-10 | 2024-09-11 | $10.65 | $53K | -7.5% | -19.7% | -18.0% |
| LXEO | SELL · 10b5-1 | 2024-08-12 | 2024-08-13 | $11.53 | $58K | +1.9% | -16.6% | -32.8% |
| LXEO | SELL · 10b5-1 | 2024-07-10 | 2024-07-12 | $16.79 | $1.8M | -16.1% | -15.0% | -43.5% |
| LXEO | SELL · 10b5-1 | 2024-06-10 | 2024-06-12 | $17.52 | $139K | -10.0% | -6.1% | -44.8% |
| LXEO | SELL · 10b5-1 | 2024-05-13 | 2024-05-14 | $13.22 | $66K | +9.0% | +32.3% | -15.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.